Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,069 | 95 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $740.48 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $351.19 | 9 | $0 (2024) |
| Amgen Inc. | $165.25 | 13 | $0 (2024) |
| Novo Nordisk Inc | $160.62 | 9 | $0 (2024) |
| EVOKE PHARMA, INC. | $109.29 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $77.12 | 3 | $0 (2024) |
| PFIZER INC. | $71.66 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $53.55 | 3 | $0 (2024) |
| Braeburn Inc. | $49.37 | 2 | $0 (2024) |
| Almatica Pharma LLC | $45.44 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,423 | 63 | ABBVIE INC. ($542.76) |
| 2023 | $646.76 | 32 | ABBVIE INC. ($197.72) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Gastroenterology | ||||||
| 08/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/12/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Gastroenterology | ||||||
| 08/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Respiratory | ||||||
| 07/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Respiratory | ||||||
| 07/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Neuroscience | ||||||
| 07/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardio-renal | ||||||
| 07/09/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Opioid Use Disorder | ||||||
| 07/02/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: HEMATOLOGY | ||||||
| 07/02/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Gastroenterology | ||||||
| 06/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Inflammation | ||||||
| 06/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Neuroscience | ||||||
| 06/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Inflammation | ||||||
| 06/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: Inflammation | ||||||
| 05/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 128 | 241 | $40,580 | $19,849 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 121 | $24,200 | $11,954 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 66 | $9,900 | $4,607 | 46.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 31 | 54 | $6,480 | $3,289 | 50.8% |
About Dr. Luis Ramos, MD
Dr. Luis Ramos, MD is a General Practice healthcare provider based in Orange City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2018. The National Provider Identifier (NPI) number assigned to this provider is 1447754825.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Ramos, MD has received a total of $2,069 in payments from pharmaceutical and medical device companies, with $1,423 received in 2024. These payments were reported across 95 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,069).
As a Medicare-enrolled provider, Ramos has provided services to 128 Medicare beneficiaries, totaling 241 services with total Medicare billing of $19,849. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Other Specialties General Practice
- Location Orange City, FL
- Active Since 03/21/2018
- Last Updated 06/26/2024
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447754825
Products in Payments
- QULIPTA (Drug) $350.97
- AIRSUPRA (Drug) $177.63
- CREON (Drug) $169.86
- Otezla (Drug) $151.89
- FARXIGA (Drug) $136.51
- GIMOTI (Drug) $109.29
- VRAYLAR (Drug) $79.69
- SPRAVATO (Drug) $77.12
- Rybelsus (Drug) $68.92
- VIBERZI (Drug) $57.55
- Ozempic (Drug) $55.72
- Kerendia (Drug) $53.55
- UBRELVY (Drug) $49.86
- BRIXADI (Drug) $49.37
- LOREEV XR (Drug) $45.44
- MOUNJARO (Drug) $44.31
- SUBLOCADE (Drug) $43.39
- BREZTRI (Drug) $37.05
- LINZESS (Drug) $32.55
- AUSTEDO (Drug) $31.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Orange City
Mr. Jay Chanmugam, Do, DO
General Practice — Payments: $7,776
Dr. Luis Barba, Md, MD
General Practice — Payments: $6,253
Gregory Prince, Arnp, Fnp-C, ARNP, FNP-C
General Practice — Payments: $5,104
Dr. Sarah Sidhom, Dmd, DMD
General Practice — Payments: $999.08
Dr. Edgar George, M.d, M.D
General Practice — Payments: $760.50
Melissa Colon
General Practice — Payments: $635.76